Single User License
INR 136340
Site License
INR 272680
Corporate User License
INR 409020

Service Tax Additional

select a format
Price

Single User License
USD 2000
Site License
USD 4000
Corporate User License
USD 6000

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Peanut Allergy-Pipeline Review, H1 2015

Peanut Allergy-Pipeline Review, H1 2015


  Request for Sample Report

Executive Summary

Peanut Allergy-Pipeline Review, H1 2015

Summary

Global Markets Direct's, 'Peanut Allergy-Pipeline Review, H1 2015', provides an overview of the Peanut Allergy's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Peanut Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peanut Allergy and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global therapeutic landscape of Peanut Allergy

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved in the therapeutics development for Peanut Allergy and enlists all their major and minor projects

The report summarizes all the dormant and discontinued pipeline projects

A review of the Peanut Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

A detailed assessment of monotherapy and combination therapy pipeline projects

Coverage of the Peanut Allergy pipeline on the basis of target, MoA, route of administration and molecule type

Latest news and deals relating related to pipeline products

Reasons To Buy

Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop strategic initiatives by understanding the focus areas of leading companies

Identify and understand important and diverse types of therapeutics under development for Peanut Allergy

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Devise corrective measures for pipeline projects by understanding Peanut Allergy pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Global Markets Direct Report Coverage 6

Peanut Allergy Overview 7

Therapeutics Development 8

Pipeline Products for Peanut Allergy-Overview 8

Pipeline Products for Peanut Allergy-Comparative Analysis 9

Peanut Allergy-Therapeutics under Development by Companies 10

Peanut Allergy-Therapeutics under Investigation by Universities/Institutes 11

Peanut Allergy-Pipeline Products Glance 12

Clinical Stage Products 12

Early Stage Products 13

Peanut Allergy-Products under Development by Companies 14

Peanut Allergy-Products under Investigation by Universities/Institutes 15

Peanut Allergy-Companies Involved in Therapeutics Development 16

BioTech Tools s.a. 16

DBV Technologies S.A. 17

HAL Allergy BV 18

Immunomic Therapeutics, Inc. 19

Peanut Allergy-Therapeutics Assessment 20

Assessment by Monotherapy Products 20

Assessment by Target 21

Assessment by Route of Administration 22

Assessment by Molecule Type 24

Drug Profiles 26

Allergen for Peanut Allergy-Drug Profile 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

Allergen for Peanut Allergy-Drug Profile 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

Allergen for Peanut Allergy-Drug Profile 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

ARA-LAMP-Vax-Drug Profile 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

DBV-712-Drug Profile 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

DN-1017-Drug Profile 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

PER-1080-Drug Profile 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

pnut-ASIT-Drug Profile 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

Recombinant Protein for Peanut Allergy-Drug Profile 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

Recombinant Vector Vaccine for Peanut Allergy-Drug Profile 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

VTC-064-Drug Profile 38

Product Description 38

Mechanism of Action 38

R&D Progress 38

Peanut Allergy-Recent Pipeline Updates 39

Peanut Allergy-Dormant Projects 44

Peanut Allergy-Discontinued Products 45

Peanut Allergy-Product Development Milestones 46

Featured News & Press Releases 46

Apr 09, 2015: DBV Technologies Receives FDA Breakthrough Therapy Designation for Viaskin Peanut for the Treatment of Peanut Allergy in Children 46

Mar 25, 2015: Immunomic Therapeutics Receives Positive Feedback From FDA Following Pre-IND Discussions for Its Proprietary Peanut Allergy Vaccine 46

Feb 24, 2015: Viaskin Data Presented at AAAAI Meeting Show Safety and Efficacy in the Treatment of Food Allergies 46

Feb 03, 2015: Largest Presence Ever of DBV Technologies at 2015 Allergy Meeting 48

Sep 22, 2014: DBV Technologies Announces Primary Endpoint Met in VIPES, Viaskin Peanut's Phase IIb Clinical Trial in Peanut Allergy 50

Jul 17, 2014: DBV Technologies Completes last food challenge visit of last Peanut-Allergic patient in VIPES Phase IIb Clinical Study 51

Jun 10, 2014: Five Scientific Communications at the European Academy of Allergy and Clinical Immunology Congress Further Support DBV's EPIT Disease Modifying Effect 52

Apr 16, 2014: DBV Announces the First reported case of a long term sustained effect of Peanut desensitization after Epicutaneous Immunotherapy with Viaskin at the French Congress of Allergy 53

Mar 17, 2014: DBV Technologies Provides VIPES Update 54

Feb 27, 2014: Allergen Research Initiates Phase 2b Clinical Trial for Peanut Allergy Oral Immunotherapy 54

Appendix 56

Methodology 56

Coverage 56

Secondary Research 56

Primary Research 56

Expert Panel Validation 56

Contact Us 56

Disclaimer 57

List of Tables

Number of Products under Development for Peanut Allergy, H1 2015 8

Number of Products under Development for Peanut Allergy-Comparative Analysis, H1 2015 9

Number of Products under Development by Companies, H1 2015 10

Number of Products under Investigation by Universities/Institutes, H1 2015 11

Comparative Analysis by Clinical Stage Development, H1 2015 12

Comparative Analysis by Early Stage Development, H1 2015 13

Products under Development by Companies, H1 2015 14

Products under Investigation by Universities/Institutes, H1 2015 15

Peanut Allergy-Pipeline by BioTech Tools s.a., H1 2015 16

Peanut Allergy-Pipeline by DBV Technologies S.A., H1 2015 17

Peanut Allergy-Pipeline by HAL Allergy BV, H1 2015 18

Peanut Allergy-Pipeline by Immunomic Therapeutics, Inc., H1 2015 19

Assessment by Monotherapy Products, H1 2015 20

Number of Products by Stage and Target, H1 2015 21

Number of Products by Stage and Route of Administration, H1 2015 23

Number of Products by Stage and Molecule Type, H1 2015 25

Peanut Allergy Therapeutics-Recent Pipeline Updates, H1 2015 39

Peanut Allergy-Dormant Projects, H1 2015 44

Peanut Allergy-Discontinued Products, H1 2015 45

List of Figures

Number of Products under Development for Peanut Allergy, H1 2015 8

Number of Products under Development for Peanut Allergy-Comparative Analysis, H1 2015 9

Number of Products under Development by Companies, H1 2015 10

Comparative Analysis by Clinical Stage Development, H1 2015 12

Comparative Analysis by Early Stage Products, H1 2015 13

Assessment by Monotherapy Products, H1 2015 20

Number of Products by Top 10 Routes of Administration, H1 2015 22

Number of Products by Stage and Top 10 Routes of Administration, H1 2015 23

Number of Products by Top 10 Molecule Types, H1 2015 24

Number of Products by Stage and Top 10 Molecule Types, H1 2015 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

BioTech Tools s.a.

DBV Technologies S.A.

HAL Allergy BV

Immunomic Therapeutics, Inc.

Peanut Allergy Therapeutic Products under Development, Key Players in Peanut Allergy Therapeutics, Peanut Allergy Pipeline Overview, Peanut Allergy Pipeline, Peanut Allergy Pipeline Assessment


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com